-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Edited by Yimaitong, please do not reprint without authorization
.
The 81st Scientific Meeting of the American Diabetes Association (ADA) in 2021 will open on the 25th of this month for 5 days
.
As in previous years, Yimaitong has been authorized by the ADA Conference Affairs Group to report on this conference
.
The exciting content will be revealed in advance: Looking at the conference schedule, this year's ADA conference will have draft guidelines for diagnosis and treatment of type 1 diabetes and a number of major research releases.
For more content, please continue to pay attention to the Endocrinology Department of Yimaitong
.
On this occasion, let’s review the 2021 ADA guidelines just released at the beginning of this year
.
This article selects the relevant content of "Drug specificity and patient factors in the selection of hypoglycemic drugs for type 2 diabetes" in the 2021 ADA guidelines to share with you
.
Figure 1 Drug specificity and patient factors in the choice of hypoglycemic drugs for type 2 diabetes Reference materials: Cai Jinghao, Zhou Jian.
Chinese Journal of Medical Frontiers (Electronic Edition), 2021, 13(02): 13-23.
.
The 81st Scientific Meeting of the American Diabetes Association (ADA) in 2021 will open on the 25th of this month for 5 days
.
As in previous years, Yimaitong has been authorized by the ADA Conference Affairs Group to report on this conference
.
The exciting content will be revealed in advance: Looking at the conference schedule, this year's ADA conference will have draft guidelines for diagnosis and treatment of type 1 diabetes and a number of major research releases.
For more content, please continue to pay attention to the Endocrinology Department of Yimaitong
.
On this occasion, let’s review the 2021 ADA guidelines just released at the beginning of this year
.
This article selects the relevant content of "Drug specificity and patient factors in the selection of hypoglycemic drugs for type 2 diabetes" in the 2021 ADA guidelines to share with you
.
Figure 1 Drug specificity and patient factors in the choice of hypoglycemic drugs for type 2 diabetes Reference materials: Cai Jinghao, Zhou Jian.
Chinese Journal of Medical Frontiers (Electronic Edition), 2021, 13(02): 13-23.